BOT - Anything but charting, page-8489

I'm interested to see if BOT even go into a trading halt for FDA Approval actually.

I'm also invested in PAA, who were recently awaiting ODD (Orphan Drug Designation) from the FDA, for a drug of theirs (Monepantel - which significantly increases life expectancy in MND sufferers). The FDA simply approved the ODD and added it to their publicly-available FDA Register during USA business hours. As this was outside ASX hours, the information was already publicly available before market open and the company did not seek a trading halt.

I do wonder if that could occur with BOT & Sofdra - the FDA may simply add it to it's 'Approved' register before BOT actually receive the communication themselves and before the ASX opens.